Hemostemix Inc. | |
Stock Exchange | Toronto Ventures Stock Exchange |
EPS |
CAD0.03 |
Market Cap |
CAD12.2 M |
Shares Outstanding |
300.9 M |
Public Float |
205.43 M |
Address |
300-5th Avenue SW Calgary Alberta T2P 3C4 Canada |
Employees | - |
Website | http://www.hemostemix.com |
Updated | 07/08/2019 |
Hemostemix, Inc. is a clinical stage biotechnology company, which engages in the development, manufacture, and commercialization of blood-derived cell therapies to treat ischemic diseases. It focuses its operation in North America. The company was founded on March 26, 2012 and is headquartered in Calgary, Canada. |